klicapital

klicapital.vc

VCMatch tracks klicapital as an investor focused on Enterprise SaaS, Healthtech, and Digital Health companies, Seed and Series A rounds, and United States, Israel, and Emerging Markets markets. Upload your deck to compare your startup against the full private matching profile.

Check Size

Not specified

Stages

Seed, Series A, Series B

Focus Areas

Enterprise SaaS, Healthtech, Digital Health

Geography

United States, Israel, and Emerging Markets

Investment Thesis

Kli Capital backs ambitious founders solving overlooked problems across the US, Israel, and Emerging Markets. The firm is composed of operators-turned-investors who actively support portfolio companies with hands-on involvement, stating ‘We like to roll up our sleeves, and help steer them to success.’ Their approach emphasizes early-stage investment with significant follow-on support, having produced top decile returns over 6 years and trending to +95th percentile returns in the last 3 years.

Is klicapital right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

See If You're a Match View Sample Match

Investment Focus

Who should take a closer look

klicapital is most relevant for founders raising Seed, Series A, and Series B rounds in Enterprise SaaS, Healthtech, Digital Health, and AI/ML, especially across United States, Israel, and Emerging Markets.

Focus statement

Invest in ambitious founders solving overlooked problems in the US, Israel, and Emerging Markets. Support early-stage companies with operational expertise and hands-on guidance.

Value Add

Team composed of operators-turned-investors with combined operational knowledge and experience
Hands-on, active involvement with portfolio companies ('roll up our sleeves' approach)
Focus on overlooked problems rather than mainstream venture areas
Geographic diversification across US, Israel, and Emerging Markets
Strong follow-on investment track record (56 follow-on investments across portfolio)
Exceptional performance metrics (top decile returns, +95th percentile in recent years)